S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
NetApp stock is about to hit 20-year highs
All the trading advice you’ve ever received boils down to this (Ad)
Ambarella: robust double-digit upside comes into focus
Retail sector resurgence: optimism grows for holiday momentum
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
These biotechs targeting multiple neurodegenerative diseases
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
NetApp stock is about to hit 20-year highs
All the trading advice you’ve ever received boils down to this (Ad)
Ambarella: robust double-digit upside comes into focus
Retail sector resurgence: optimism grows for holiday momentum
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
These biotechs targeting multiple neurodegenerative diseases
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
NetApp stock is about to hit 20-year highs
All the trading advice you’ve ever received boils down to this (Ad)
Ambarella: robust double-digit upside comes into focus
Retail sector resurgence: optimism grows for holiday momentum
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
These biotechs targeting multiple neurodegenerative diseases
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
15 best consumer discretionary stocks for the rest of 2023
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Energy traders: A rebound is coming
NetApp stock is about to hit 20-year highs
All the trading advice you’ve ever received boils down to this (Ad)
Ambarella: robust double-digit upside comes into focus
Retail sector resurgence: optimism grows for holiday momentum
All the trading advice you’ve ever received boils down to this (Ad)
Behind the tech boom: Big price leaders selectively laying off
These biotechs targeting multiple neurodegenerative diseases

Viemed Healthcare Stock Price, News & Analysis (NASDAQ:VMD)

$7.66
-0.11 (-1.42%)
(As of 12/1/2023 ET)
Compare
Today's Range
$7.54
$7.73
50-Day Range
$6.04
$8.22
52-Week Range
$5.90
$12.01
Volume
107,997 shs
Average Volume
85,018 shs
Market Capitalization
$294.83 million
P/E Ratio
33.31
Dividend Yield
N/A
Price Target
N/A

VMD stock logo

About Viemed Healthcare Stock (NASDAQ:VMD)

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

VMD Stock Price History

VMD Stock News Headlines

Viemed Healthcare Inc Ordinary Shares VMD
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Viemed Healthcare Q3 2023 Earnings Preview
3 Medical Stocks Investors Are Buying for Growth
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Closing Bell: Viemed Healthcare Inc flat on Thursday (VMD)
Viemed Healthcare Earnings Preview
1 Soaring Health Care Stock to Watch Today
Closing Bell: Viemed Healthcare Inc down on Monday (VMD)
Closing Bell: Viemed Healthcare Inc up on Wednesday (VMD)
Stocks in play: Viemed Healthcare, Inc.
Closing Bell: Viemed Healthcare Inc up on Tuesday (VMD)
Closing Bell: Viemed Healthcare Inc up on Friday (VMD)
See More Headlines
Receive VMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viemed Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2023
Today
12/02/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/07/2024

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VMD
Fax
N/A
Employees
988
Year Founded
N/A

Profitability

Net Income
$6.22 million
Pretax Margin
7.60%

Debt

Sales & Book Value

Annual Sales
$138.83 million
Cash Flow
$0.57 per share
Book Value
$2.83 per share

Miscellaneous

Free Float
31,099,000
Market Cap
$294.83 million
Optionable
Not Optionable
Beta
1.52
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Casey Hoyt (Age 46)
    CEO & Director
    Comp: $921.36k
  • Mr. Michael B. Moore CRT (Age 45)
    President
    Comp: $808.11k
  • Mr. Trae Paul Fitzgerald (Age 34)
    Chief Financial Officer
    Comp: $409.57k
  • Mr. William Todd Zehnder (Age 48)
    COO & Director
    Comp: $791.77k
  • Dr. William Dana Frazier M.D. (Age 65)
    Chief Medical Officer & Director
    Comp: $255.71k
  • Mr. Jeremy Trahan
    Chief Legal Officer and Executive VP of Acquisitions & Strategic Transactions
  • Mr. Michael Freeman
    Chief Business Development Officer
  • Mr. Patrick Ewell Eagan (Age 44)
    General Counsel & Corporate Secretary














VMD Stock Analysis - Frequently Asked Questions

How have VMD shares performed in 2023?

Viemed Healthcare's stock was trading at $7.56 at the beginning of the year. Since then, VMD shares have increased by 1.3% and is now trading at $7.66.
View the best growth stocks for 2023 here
.

Are investors shorting Viemed Healthcare?

Viemed Healthcare saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 253,200 shares, a drop of 20.3% from the October 31st total of 317,700 shares. Based on an average daily volume of 93,400 shares, the short-interest ratio is currently 2.7 days. Approximately 0.8% of the company's shares are sold short.
View Viemed Healthcare's Short Interest
.

When is Viemed Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 7th 2024.
View our VMD earnings forecast
.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (NASDAQ:VMD) posted its earnings results on Wednesday, November, 1st. The company reported $0.07 earnings per share for the quarter. The firm had revenue of $49.40 million for the quarter. Viemed Healthcare had a trailing twelve-month return on equity of 8.97% and a net margin of 5.42%.

What guidance has Viemed Healthcare issued on next quarter's earnings?

Viemed Healthcare issued an update on its fourth quarter 2023 earnings guidance on Wednesday, November, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $49.80 million-$51.00 million, compared to the consensus revenue estimate of $52.00 million.

Who are Viemed Healthcare's major shareholders?

Viemed Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (3.12%), Cove Street Capital LLC (2.45%), Acadian Asset Management LLC (2.08%), Punch & Associates Investment Management Inc. (1.33%), Connor Clark & Lunn Investment Management Ltd. (1.07%) and Tocqueville Asset Management L.P. (1.03%). Insiders that own company stock include Nitin Kaushal and Timothy Smokoff.
View institutional ownership trends
.

How do I buy shares of Viemed Healthcare?

Shares of VMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:VMD) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -